3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol

C125H142F2N36O9 — CID 158427812

IUPAC3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol
SMILESCC(C)Oc1cc2c(-c3ccnc(N4CCC(C)(O)C4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCC(F)(F)CC4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCN(CC5CC5)CC4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCc5nc(C6CC6)oc5C4)c3)n[nH]c2cn1.CCc1nnc2n1CCN(c1cc(-c3n[nH]c4cnc(OC(C)C)cc34)ccn1)C2.Cc1nc2c(o1)CN(c1cc(-c3n[nH]c4cnc(OC(C)C)cc34)ccn1)CC2
InChIInChI=1S/C23H24N6O2.C22H28N6O.C21H24N8O.C21H22N6O2.C19H21F2N5O.C19H23N5O2/c1-13(2)30-21-10-16-18(11-25-21)27-28-22(16)15-5-7-24-20(9-15)29-8-6-17-19(12-29)31-23(26-17)14-3-4-14;1-15(2)29-21-12-18-19(13-24-21)25-26-22(18)17-5-6-23-20(11-17)28-9-7-27(8-10-28)14-16-3-4-16;1-4-17-25-26-19-12-28(7-8-29(17)19)18-9-14(5-6-22-18)21-15-10-20(30-13(2)3)23-11-16(15)24-27-21;1-12(2)28-20-9-15-17(10-23-20)25-26-21(15)14-4-6-22-19(8-14)27-7-5-16-18(11-27)29-13(3)24-16;1-12(2)27-17-10-14-15(11-23-17)24-25-18(14)13-3-6-22-16(9-13)26-7-4-19(20,21)5-8-26;1-12(2)26-17-9-14-15(10-21-17)22-23-18(14)13-4-6-20-16(8-13)24-7-5-19(3,25)11-24/h5,7,9-11,13-14H,3-4,6,8,12H2,1-2H3,(H,27,28);5-6,11-13,15-16H,3-4,7-10,14H2,1-2H3,(H,25,26);5-6,9-11,13H,4,7-8,12H2,1-3H3,(H,24,27);4,6,8-10,12H,5,7,11H2,1-3H3,(H,25,26);3,6,9-12H,4-5,7-8H2,1-2H3,(H,24,25);4,6,8-10,12,25H,5,7,11H2,1-3H3,(H,22,23)
InChIKeyHBGSJBYIHKIXIK-UHFFFAOYSA-N
MW2330.75 g/mol
LogP21.03
Rot. Bonds28

About 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol

3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol (PubChem CID 158427812) has the molecular formula C125H142F2N36O9 and a molecular weight of 2330.75 g/mol. Its IUPAC name is 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol.

Molecular Properties

Compound Name3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol
PubChem CID158427812
Molecular FormulaC125H142F2N36O9
Molecular Weight2330.75 g/mol
Exact Mass2329.17
IUPAC Name3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol
SMILESCC(C)Oc1cc2c(-c3ccnc(N4CCC(C)(O)C4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCC(F)(F)CC4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCN(CC5CC5)CC4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCc5nc(C6CC6)oc5C4)c3)n[nH]c2cn1.CCc1nnc2n1CCN(c1cc(-c3n[nH]c4cnc(OC(C)C)cc34)ccn1)C2.Cc1nc2c(o1)CN(c1cc(-c3n[nH]c4cnc(OC(C)C)cc34)ccn1)CC2
InChIInChI=1S/C23H24N6O2.C22H28N6O.C21H24N8O.C21H22N6O2.C19H21F2N5O.C19H23N5O2/c1-13(2)30-21-10-16-18(11-25-21)27-28-22(16)15-5-7-24-20(9-15)29-8-6-17-19(12-29)31-23(26-17)14-3-4-14;1-15(2)29-21-12-18-19(13-24-21)25-26-22(18)17-5-6-23-20(11-17)28-9-7-27(8-10-28)14-16-3-4-16;1-4-17-25-26-19-12-28(7-8-29(17)19)18-9-14(5-6-22-18)21-15-10-20(30-13(2)3)23-11-16(15)24-27-21;1-12(2)28-20-9-15-17(10-23-20)25-26-21(15)14-4-6-22-19(8-14)27-7-5-16-18(11-27)29-13(3)24-16;1-12(2)27-17-10-14-15(11-23-17)24-25-18(14)13-3-6-22-16(9-13)26-7-4-19(20,21)5-8-26;1-12(2)26-17-9-14-15(10-21-17)22-23-18(14)13-4-6-20-16(8-13)24-7-5-19(3,25)11-24/h5,7,9-11,13-14H,3-4,6,8,12H2,1-2H3,(H,27,28);5-6,11-13,15-16H,3-4,7-10,14H2,1-2H3,(H,25,26);5-6,9-11,13H,4,7-8,12H2,1-3H3,(H,24,27);4,6,8-10,12H,5,7,11H2,1-3H3,(H,25,26);3,6,9-12H,4-5,7-8H2,1-2H3,(H,24,25);4,6,8-10,12,25H,5,7,11H2,1-3H3,(H,22,23)
InChIKeyHBGSJBYIHKIXIK-UHFFFAOYSA-N
XLogP21.03
TPSA507.82 Ų
H-Bond Donors7
H-Bond Acceptors39
Rotatable Bonds28
Heavy Atoms172
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002330.75
LogP ≤ 521.03
H-Bond Donors ≤ 57
H-Bond Acceptors ≤ 1039

Analyze 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol?
The IUPAC name of 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol (CID 158427812) is 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol.
What is the SMILES notation for 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol?
The canonical SMILES for 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol is CC(C)Oc1cc2c(-c3ccnc(N4CCC(C)(O)C4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCC(F)(F)CC4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCN(CC5CC5)CC4)c3)n[nH]c2cn1.CC(C)Oc1cc2c(-c3ccnc(N4CCc5nc(C6CC6)oc5C4)c3)n[nH]c2cn1.CCc1nnc2n1CCN(c1cc(-c3n[nH]c4cnc(OC(C)C)cc34)ccn1)C2.Cc1nc2c(o1)CN(c1cc(-c3n[nH]c4cnc(OC(C)C)cc34)ccn1)CC2.
What is the InChIKey of 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol?
The InChIKey is HBGSJBYIHKIXIK-UHFFFAOYSA-N. The full InChI is InChI=1S/C23H24N6O2.C22H28N6O.C21H24N8O.C21H22N6O2.C19H21F2N5O.C19H23N5O2/c1-13(2)30-21-10-16-18(11-25-21)27-28-22(16)15-5-7-24-20(9-15)29-8-6-17-19(12-29)31-23(26-17)14-3-4-14;1-15(2)29-21-12-18-19(13-24-21)25-26-22(18)17-5-6-23-20(11-17)28-9-7-27(8-10-28)14-16-3-4-16;1-4-17-25-26-19-12-28(7-8-29(17)19)18-9-14(5-6-22-18)21-15-10-20(30-13(2)3)23-11-16(15)24-27-21;1-12(2)28-20-9-15-17(10-23-20)25-26-21(15)14-4-6-22-19(8-14)27-7-5-16-18(11-27)29-13(3)24-16;1-12(2)27-17-10-14-15(11-23-17)24-25-18(14)13-3-6-22-16(9-13)26-7-4-19(20,21)5-8-26;1-12(2)26-17-9-14-15(10-21-17)22-23-18(14)13-4-6-20-16(8-13)24-7-5-19(3,25)11-24/h5,7,9-11,13-14H,3-4,6,8,12H2,1-2H3,(H,27,28);5-6,11-13,15-16H,3-4,7-10,14H2,1-2H3,(H,25,26);5-6,9-11,13H,4,7-8,12H2,1-3H3,(H,24,27);4,6,8-10,12H,5,7,11H2,1-3H3,(H,25,26);3,6,9-12H,4-5,7-8H2,1-2H3,(H,24,25);4,6,8-10,12,25H,5,7,11H2,1-3H3,(H,22,23).
What are the key properties of 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol?
3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol has a molecular weight of 2330.75 g/mol, XLogP of 21.03, 28 rotatable bonds, 7 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 3-[2-[4-(cyclopropylmethyl)piperazin-1-yl]-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;2-cyclopropyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-[2-(4,4-difluoropiperidin-1-yl)-4-pyridinyl]-5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridine;3-ethyl-7-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazine;2-methyl-5-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]-6,7-dihydro-4H-[1,3]oxazolo[5,4-c]pyridine;3-methyl-1-[4-(5-propan-2-yloxy-1H-pyrazolo[3,4-c]pyridin-3-yl)-2-pyridinyl]pyrrolidin-3-ol is sourced from PubChem (CID 158427812), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).